ScreenerHero

LIVNLivaNova PLC

NAS · US · Healthcare · Medical Devices · livanova.com
78.74USDMkt Cap: 4.34B $P/E: 23.23

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulm…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$203.17BUSDP/E 37.7
SYK
Stryker Corporation
$126.37BUSDP/E 34.2
MDT
Medtronic plc
$119.49BUSDP/E 25.0
BSX
Boston Scientific Corporation
$73.00BUSDP/E 20.4
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
EW
Edwards Lifesciences Corporation
$51.70BUSDP/E 53.4
DXCM
DexCom, Inc.
$34.85BUSDP/E 36.5
GEHC
GE HealthCare Technologies Inc. Common Stock
$34.04BUSDP/E 17.2
PHIA
Koninklijke Philips N.V.
$25.08BUSDP/E 20.7
PHG
Koninklijke Philips N.V.
$26.80BUSDP/E 20.8
STE
STERIS plc
$23.20BUSDP/E 29.1
ZBH
Zimmer Biomet Holdings, Inc.
$19.26BUSDP/E 24.5
PEN
Penumbra, Inc.
$12.81BUSDP/E 79.7
SNN
Smith & Nephew plc
$12.25BUSDP/E 19.9
SN
Smith & Nephew plc
$11.48BUSDP/E 19.8
GMED
Globus Medical, Inc.
$11.67BUSDP/E 22.2
GKOS
Glaukos Corp
$10.91BUSD
EUZ
Eckert & Ziegler Strahlen-und Medizinte AG
$10.01BUSDP/E 17.1
PODD
Insulet Corporation
$10.28BUSDP/E 27.5
BIO
Bio-Rad Laboratories, Inc. Class A
$10.17BUSDP/E 46.3

Key Statistics

Company
Market Cap4.34B $
Enterprise Value4.14B $
Revenue (TTM)1.47B $
Gross Profit939.87M $
Net Income (TTM)-242.47M $
Revenue/Share26.89 USD
Last Price78.74 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.3K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)23.23
P/E (Forward)16.72
PEG0.93
EV/EBITDA15.47
EV/Revenue2.82
P/S2.92
P/B3.25
EPS (TTM)3.39
EPS (Forward)4.68
52W Range
77.9450% of range79.56
52W High79.56 USD
52W Low77.94 USD
Profitability
Gross Margin67.71%
Oper. Margin15.52%
EBITDA Margin18.20%
Profit Margin-17.47%
ROE-20.21%
ROA-9.30%
Growth
Revenue Growth10.80%
Earnings Growth287.80%
Cash Flow & Leverage
Operating CF254.34M $
CapEx (TTM)81.05M $
FCF Margin4.40%
FCF Yield1.49%
Net Debt-164.67M $
Net Debt/EBITDA-0.61
Balance Sheet
Debt/Equity0.36
Current Ratio1.45
Quick Ratio1.08
Book Value/Sh24.07 USD
Cash/Share9.377 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)88.80 USD
Upside (mean)+12.8%
Target Range75.00 USD – 100.00 USD
$75.00+12.8% to mean$100.00
# Analysts10
Ownership
Shares Out.55.09M
Float54.83M
Insiders0.42%
Institutions113.18%
Short Interest
Short Ratio7.4d
Short % Float8.64%
Short % Out.7.52%
Shares Short4.14M
Short (prev mo.)3.94M
Technical
SMA 5080.47 (-2.1%)
SMA 20068.16 (+15.5%)
Beta0.87
S&P 52W Chg21.00%
Avg Vol (30d)424.75K
Avg Vol (10d)660.09K
Technical Indicators
RSI (14)47.0
MACD-0.0719
MACD Signal0.0575
MACD Hist.-0.1294
BB Upper84.94 USD
BB Middle80.13 USD
BB Lower75.32 USD
BB Width12.01%
ATR (14)2.642 USD
Vol Ratio (20d)0.61x